A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent IDH-mutant Astrocytoma or Oligodendroglioma

NCT07120984 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioma

Interventions

BIOLOGICAL: L19TNF
BIOLOGICAL: L19TNF and TMZ
BIOLOGICAL: L19TNF and CCNU
BIOLOGICAL: L19TNF monotherapy
BIOLOGICAL: L19TNF and TMZ in recurrent astrocytoma
BIOLOGICAL: L19TNF and CCNU in recurrent astrocytoma
BIOLOGICAL: L19TNF monothery in recurrent oligodendroglioma

Sponsor

Philogen S.p.A.